Non-Billable / Non-Specific Code
ICD-10-CM C69 is the diagnosis code for Malignant neoplasm of eye and adnexa. This code falls under the section "Malignant neoplasms of eye, brain and other parts of central nervous system" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C69. They are mutually exclusive:
Understanding where C69 sits in the ICD-10-CM classification helps ensure proper coding:
No, C69 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C69 is the ICD-10-CM diagnosis code for "Malignant neoplasm of eye and adnexa". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C69 is located in Section C69-C72 — "Malignant neoplasms of eye, brain and other parts of central nervous system" within Chapter 2 of the ICD-10-CM Tabular List.
C69 has 9 sub-code(s) that provide more specific detail: C69.0, C69.1, C69.2, C69.3, C69.4 and more.
Use C69 when the patients documented diagnosis matches "Malignant neoplasm of eye and adnexa" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of eye and adnexa is C69.
No, C69 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C69 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C69 include: malignant neoplasm of connective tissue of eyelid (C49.0); malignant neoplasm of eyelid (skin) (C43.1-, C44.1-); malignant neoplasm of optic nerve (C72.3-).
Yes, C69 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.